# Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

> **NCT00017537** · PHASE1 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Breast Cancer
- Gastric Cancer
- Lung Cancer
- Ovarian Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** MVF-HER-2(628-647)-CRL 1005 vaccine

## Key facts

- **NCT ID:** NCT00017537
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2000-03
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017537, "Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00017537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*